1. Gilead Sciences Names Roche's O'Day as CEO and Chairman

    Gilead Sciences Names Roche's O'Day as CEO and Chairman

    Biopharmaceutical giant Gilead Sciences Inc. named Daniel O'Day, who heads Roche Holding AG's pharmaceuticals business, as its next CEO.  The California-based company's board...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned